Atrás
Rango del Día
$28.96
$31.36
Rango de 52 Semanas
$13.30
$31.76
Volumen
874,656
Promedio 50D / 200D
$27.54
/
$21.92
Cierre Anterior
$29.03
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -17.8 | 0.4 |
| P/B | 4.0 | 2.9 |
| ROE % | -27.0 | 3.8 |
| Net Margin % | — | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.0 | 0.2 |
Precio Objetivo de Analistas
Hold
$43.33
+40.6%
Low: $39.00
High: $52.00
EPS Futuro
-$2.12
Ingresos Est.
10000
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
-$1.90
-$1.90 – -$1.90
|
210 M | 1 |
| FY2029 |
-$3.47
-$3.47 – -$3.47
|
41 M | 1 |
| FY2028 |
-$3.81
-$5.11 – -$1.93
|
25000 | 5 |
Puntos Clave
Debt/Equity of 0.00 — conservative balance sheet
Negative free cash flow of -70.46M
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-26.95%
ROIC-19.51%
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
0.00
Current Ratio28.66
Interest Coverage0.00
Valoración
P/E Ratio
-17.77
P/B Ratio4.01
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -103.69M |
| ROE | -26.95% | ROA | -21.78% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -70.46M |
| ROIC | -19.51% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 28.66 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -17.77 | P/B Ratio | 4.01 |
| P/S Ratio | N/A | PEG Ratio | 2.65 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 1.84B | Enterprise Value | 1.74B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -103.69M | -89.02M | -71.58M | -37.66M | -24.74M |
| EPS (Diluted) | -1.83 | -1.89 | -2.01 | -6.03 | -3.17 |
| Gross Profit | -263,000.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | -119.66M | -104.55M | -83.53M | -38.79M | -24.76M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 476.17M | 325.76M | 271.87M | 83.30M | 113.33M |
| Total Liabilities | 16.68M | 15.92M | 25.96M | 160.12M | 6.47M |
| Shareholders' Equity | 459.60M | 309.85M | 245.91M | -76.83M | 106.86M |
| Total Debt | 399,000.0 | 0.0 | 335,000.0 | 323,000.0 | 159,000.0 |
| Cash & Equivalents | 98.90M | 124.12M | 100.14M | 75.54M | 110.02M |
| Current Assets | 474.88M | 318.13M | 266.15M | 77.75M | 110.67M |
| Current Liabilities | 16.57M | 15.92M | 25.89M | 9.72M | 5.75M |